Enalaprilat Injection Shortage
Last Updated: April 12, 2021
Status: Resolved
Reason for the Shortage
-
- Hikma had enalaprilat injection on shortage due to increased demand.
- Pfizer is not marketing enalaprilat injection.
Available Products
-
- Enalaprilat injection, Hikma, 1.25 mg/mL, 1 mL vial, 10 count, NDC 00143-9787-10
- Enalaprilat injection, Hikma, 1.25 mg/mL, 2 mL vial, 10 count, NDC 00143-9786-10
Estimated Resupply Dates
-
- Hikma has enalaprilat 1.25 mg/mL 1 mL and 2 mL vials available.
Updated
Updated April 12, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 31, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.